The concept of treatment-free remission in chronic myeloid leukemia

The advent of tyrosine kinase inhibitors (TKI) into the management of patients with chronic myeloid leukemia (CML) has profoundly improved prognosis. Survival of responders is approaching that of the general population but lifelong treatment is still recommended. In several trials, TKI treatment has...

Descripción completa

Detalles Bibliográficos
Autores principales: Saußele, S, Richter, J, Hochhaus, A, Mahon, F-X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980559/
https://www.ncbi.nlm.nih.gov/pubmed/27133824
http://dx.doi.org/10.1038/leu.2016.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980559/
https://www.ncbi.nlm.nih.gov/pubmed/27133824
http://dx.doi.org/10.1038/leu.2016.115

Ejemplares similares